CDT Highlights Sarborg's Quantum Computing IP For Drug Discovery

CDT Equity (CDT) said Sarborg filed new IP applying quantum sampling to disease biology and drug discovery. Its model analyzed 150 disease networks, including Crohn's disease, COPD and psoriasis, identifying potential drug targets.